Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lophos Holdings, Inc. (TSE:MESC)
CNQX:MESC
Lophos Holdings, Inc. (MESC) Stock Price & Analysis
1 Followers
MESC Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.30
Previous CloseC$0.03
Volume344.10K
Average Volume (3M)132.81K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)C$203.29K
Total Debt (Recent Filing)C$1.91M
Price to Earnings (P/E)―
Beta-0.58
Next Earnings
Feb 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding85,859,673
10 Day Avg. Volume114,262
30 Day Avg. Volume132,815
Standard Deviation0.39
R-Squared0.17
Alpha0.14
Financial Highlights & Ratios
Price to Book (P/B)1.75
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lophos Holdings, Inc. News
PremiumCompany Announcements
Lophos Holdings Completes Deal with ThreeD Capital
PremiumCompany Announcements
Lophos Honors Roots with Peyote Blessing Ceremony
PremiumCompany Announcements
Lophos Holdings Set to Acquire Magicactus Assets
PremiumCompany Announcements
Lophos Holdings Set to Acquire Magicactus Assets
PremiumCompany Announcements
Lophos Embarks on Sustainable Peyote Cultivation Study
PremiumCompany Announcements
Lophos Holdings Triples Peyote Cultivation Goals
PremiumCompany Announcements
Lophos Holdings Accelerates Bioscience GrowthOptions Prices
Currently, No data available
---
Ownership Overview
5.55% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
94.45% Public Companies and
Individual Investors
MESC FAQ
What was Lophos Holdings, Inc.’s price range in the past 12 months?
Lophos Holdings, Inc. lowest stock price was C$0.02 and its highest was C$0.30 in the past 12 months.
What is Lophos Holdings, Inc.’s market cap?
Currently, no data Available
When is Lophos Holdings, Inc.’s upcoming earnings report date?
Lophos Holdings, Inc.’s upcoming earnings report date is Feb 29, 2024 which is 145 days ago.
How were Lophos Holdings, Inc.’s earnings last quarter?
Lophos Holdings, Inc. released its earnings results on Nov 30, 2023. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is Lophos Holdings, Inc. overvalued?
According to Wall Street analysts Lophos Holdings, Inc.’s price is currently Overvalued.
Does Lophos Holdings, Inc. pay dividends?
Lophos Holdings, Inc. does not currently pay dividends.
What is Lophos Holdings, Inc.’s EPS estimate?
Lophos Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lophos Holdings, Inc. have?
Lophos Holdings, Inc. has 73,834,670 shares outstanding.
What happened to Lophos Holdings, Inc.’s price movement after its last earnings report?
Lophos Holdings, Inc. reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Lophos Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:MESC
---
Company Description
Lophos Holdings, Inc.
Lophos Holdings Inc. se rapporte à la culture et à la recherche de Lophophora williamsii (« cactus peyotl »). De plus, à long terme, la Société est engagée dans la recherche et le développement de composés dérivés du cactus peyotl. La filiale en propriété exclusive de la société, Lophos Pharmaceuticals Corp., est une société de biosciences spécialisée dans la culture, la recherche et la vente de cactus peyotl. Elle est également autorisée à posséder, produire, vendre/fournir, envoyer, transporter et livrer les substances contrôlées couvertes par sa licence de revendeur de substances contrôlées (CSDL), à savoir la mescaline, la psilocine et la psilocybine.
---
Technical Analysis
---